NYSE$HR
Healthcare Realty Trust Inc · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Announced results for the fourth quarter ended December 31, 2023.
Healthcare Realty Trust reported a net loss attributable to common stockholders of $(40.5) million, or $(0.11) per diluted common share, for the quarter ended December 31, 2023. Normalized FFO for the three months ended December 31, 2023 totaled $150.7 million, or $0.39 per diluted common share. Merger Combined Same Store cash NOI for the fourth quarter increased 2.7% over the prior year.
- Net loss attributable to common stockholders was $(40.5) million or $(0.11) per diluted common share.
- Normalized FFO per share totaled $0.39.
- Merger Combined Same Store cash NOI increased 2.7% over the prior year.
- Multi-tenant portfolio had sequential occupancy improvement of 175,000 square feet, or 53 basis points.
Headline financials
Revenue & EPS history
Healthcare Realty · Revenue · Quarterly
$330M
Revenue by segment
Healthcare Realty · $4.26M total across 1 segment · Q3 2023
- Interest Income$4.26M+26.7%100.0%
Forward guidance
The Company's 2024 guidance range represents the in-place portfolio as of February 16, 2024, and does not include any assumptions for prospective acquisitions, joint venture seed portfolios or other related balance sheet activities that have not closed unless otherwise noted.
Tailwinds
- Multi-tenant cash NOI 3.5% to 4.75% growth
- Single-tenant cash NOI 0.5% to 1.5% growth
- Return to run-rate Performance based compensation
- January 2024 expiration of 1.21% Interest rate swap maturity
- Expected normalized FFO $584,500 to $604,000
Headwinds
- Straight-line rent
- Interest rate swap maturity
- Re/development and other capital funding $150-$250 million of dispositions
- Expected normalized FFO per share $1.52 to $1.58
- The Company's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
-0.6%
Avg return
Earnings day
+0.1%
Avg return
5 days after
-0.2%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+5.8%
Q3 2022
Best reaction
-10.1%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.9% | +8.2% | +6.6% | |
| Q4 2025 | +2.7% | +3.1% | +2.8% | |
| Q3 2025 | -0.6% | +1.0% | +2.6% | |
| Q1 2025 | -4.4% | -4.3% | -8.7% | |
| Q4 2024 | -1.3% | -1.0% | -2.2% | |
| Q3 2024 | -5.3% | -5.1% | +1.0% | |
| Q2 2024 | -0.3% | +0.8% | +1.7% | |
| Q1 2024 | +2.1% | +2.5% | +10.2% | |
| Q4 2023 | -10.1% | -8.8% | -17.8% | |
| Q3 2023 | +1.1% | -1.1% | +5.1% | |
| Q2 2023 | -6.0% | -8.5% | -15.3% | |
| Q1 2023 | -1.5% | +0.6% | -1.4% | |
| Q4 2022 | +0.7% | -4.0% | -5.9% | |
| Q3 2022 | +5.8% | +0.4% | +0.6% | |
| Q2 2022 | +3.6% | +3.9% | -4.0% | |
| Q1 2022 | -0.2% | -2.4% | -9.8% | |
| Q4 2021 | -8.8% | -4.5% | -5.2% | |
| Q3 2021 | +1.2% | +1.8% | -0.9% | |
| Q2 2021 | -2.6% | -0.5% | -2.3% | |
| Q1 2021 | +2.5% | +0.8% | -1.4% | |
| Q4 2020 | +0.4% | +0.7% | -0.3% | |
| Q3 2020 | +4.6% | +7.3% | +3.8% | |
| Q2 2020 | +1.6% | -1.6% | +2.8% | |
| Q1 2020 | +4.0% | +9.2% | +10.0% | |
| Q4 2019 | +1.2% | +1.8% | -6.3% | |
| Q3 2019 | -6.6% | -7.4% | -4.6% | |
| Q2 2019 | -1.1% | -0.6% | +2.2% | |
| Q1 2019 | -0.4% | +0.3% | +4.4% | |
| Q4 2018 | +2.0% | +2.7% | +0.4% | |
| Q3 2018 | -1.3% | +2.5% | +11.3% | |
| Q2 2018 | +2.7% | +4.1% | +4.0% | |
| Q1 2018 | +1.8% | +1.2% | +0.4% | |
| Q4 2017 | -2.1% | -0.8% | -1.5% | |
| Q3 2017 | +0.4% | +1.3% | +2.9% | |
| Q2 2017 | +0.3% | -0.3% | +0.5% | |
| Q1 2017 | -1.5% | +1.0% | +7.3% | |
| Q4 2016 | +2.7% | +2.8% | +3.4% | |
| Q3 2016 | -3.6% | -1.4% | -5.5% | |
| Q2 2016 | +0.3% | -0.6% | -0.5% | |
| Q1 2016 | +0.6% | — | — | |
| Q4 2015 | -1.4% | — | — | |
| Q3 2015 | -0.7% | — | — | |
| Q2 2015 | -0.2% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +2.0% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2014 | -1.2% | — | — | |
| Q1 2014 | -1.6% | — | — | |
| Q4 2013 | +1.1% | — | — | |
| Q3 2013 | -2.5% | — | — | |
| Q2 2013 | -3.9% | — | — | |
| Q1 2013 | +0.7% | — | — | |
| Q4 2012 | -1.8% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | -0.9% | — | — | |
| Q1 2012 | -4.0% | — | — | |
| Q1 2011 | -4.0% | — | — | |
| Q4 2009 | +1.1% | — | — | |
| Q4 2011 | +1.1% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q4 2010 | +3.4% | — | — | |
| Q2 2011 | +3.4% | — | — | |
| Q3 2010 | -6.4% | — | — | |
| Q2 2010 | -0.9% | — | — | |
| Q1 2010 | -6.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro